Invention Grant
- Patent Title: Cell targeting conjugates
- Patent Title (中): 细胞靶向缀合物
-
Application No.: US10590784Application Date: 2005-02-25
-
Publication No.: US08097238B2Publication Date: 2012-01-17
- Inventor: Roger Francis Martin , Jonathan Michael White , Pavel Nikolaevich Lobachevsky , Thomas Chris Karagiannis
- Applicant: Roger Francis Martin , Jonathan Michael White , Pavel Nikolaevich Lobachevsky , Thomas Chris Karagiannis
- Applicant Address: AU East Melbourne
- Assignee: Peter MacCallum Cancer Institute
- Current Assignee: Peter MacCallum Cancer Institute
- Current Assignee Address: AU East Melbourne
- Agency: Sughrue Mion, PLLC
- Priority: AU2004901013 20040227
- International Application: PCT/AU2005/000266 WO 20050225
- International Announcement: WO2005/082894 WO 20050909
- Main IPC: A61K51/00
- IPC: A61K51/00 ; A61M36/14

Abstract:
The present invention relates to cell targeting conjugates and in particular, but not exclusively, to methods of their use in selectively eliminating and in selectively imaging target cells. The invention also relates to processes for production of the conjugates and to intermediate compounds that may be used in production of a specific class of cell targeting conjugates. In one embodiment there is provided a cell targeting conjugate comprising the following components that are covalently conjugated via a linker that is degradable within the target cells: i) a DNA minor groove binding ligand incorporating an effective Auger electron-emitting and/or gamma-emitting and/or positron-emitting atom or photoactive moiety; ii) a target cell specific protein or peptide that is capable of internalization by target cells.
Public/Granted literature
- US20070140970A1 Cell targeting conjugates Public/Granted day:2007-06-21
Information query